BiomX closes private placement, issues 3,300 Series Y Preferred shares; appoints director

BiomX Inc.

Closed private placement of 3,300 Series Y Convertible Preferred shares and warrants on January 13, 2026.
Board appointed Reuven Yeganeh as Class 1 director, effective at closing; board size increased to nine.
Yeganeh is CEO of Continual Ltd. and independent under NYSE American rules; since 2024 also director of Nukkleus Inc.
Company entered into standard indemnification agreement with Yeganeh.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.7

BiomX Inc.: Filed Certificate of Designations for Series Y Convertible Preferred Stock, creating a new series of preferred stock with specific rights and preferences (effective 2026-01-13).

Change: charter amendment
Effective: 2026-01-13

Exact text from the filing

On January 13, 2026, the Company filed a Certificate of Designations of Series Y Convertible Preferred Stock (the “Certificate of Designations”) with the Secretary of State of the State of Delaware

View on SEC.gov

42 governance changes filed in the last 30 days. Browse all governance changes →

BiomX Inc. filing history →

Source: SEC EDGAR

accession 0001213900-26-004348

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.